GYRE Average Annual Return 10 Years

Growth of $10,000.00
With Dividends Reinvested Into GYRE

Also see:
• GYRE stock yearly return 2016
• GYRE stock yearly return 2017
• GYRE stock yearly return 2018
• GYRE stock yearly return 2019
• GYRE stock yearly return 2020
• GYRE stock yearly return 2021
• GYRE stock yearly return 2022
• GYRE stock yearly return 2023
• GYRE stock yearly return 2024
• GYRE stock yearly return 2025
• GYRE YTD return

Compare GYRE average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	03/15/2016
End date:	03/13/2026
Start price/share:	$1.86
End price/share:	$7.56
Starting shares:	5,376.34
Ending shares:	39,909.02
Dividends reinvested/share:	$1.67
Total return:	2,917.12%
GYRE Average Annual Return:	40.59%
Starting investment:	$10,000.00
Ending investment:	$301,678.46

GYRE average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Gyre Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in the research, development, manufacturing, and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of F351 (Hydronidone) for the treatment of Nonalcoholic Steatohepatitis Treatment (NASH)-associated fibrosis. Co. is also advancing a diverse pipeline in the China through its indirect controlling interest in Gyre Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230. Co. operates through two segments: Gyre Pharmaceuticals, and Gyre after the Contributions. The GYRE average annual return 10 years is shown above.

The Average Annual Return on the GYRE average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether GYRE average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GYRE average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free GYRE Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Gyre Therapeutics (GYRE) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

HAE Average Annual Return
HALO Average Annual Return
HBIO Average Annual Return
HCA Average Annual Return
HCWB Average Annual Return
HEPA Average Annual Return
HIMS Average Annual Return
HOLX Average Annual Return
HOOK Average Annual Return
HOTH Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Gyre Therapeutics (GYRE) ranks in the top 25% of all stocks whose returns we have reviewed.

What has the average annual return been for GYRE over the past ten years?

✔️Accepted answer: The ten year GYRE average annual return has been 40.59% with dividends reinvested.

When you say 'with dividends reinvested' what does that mean?

✔️Accepted answer: That means that each time the stock goes ex-dividend, the average annual return calculation then factors in how that dividend amount could have been reinvested into more shares of GYRE at the then-current price — often this is referred to as 'compounding' and is very important when considering average annual return over a long period like a full decade.

What start date was used in your GYRE average annual return calculation?

✔️Accepted answer: The start date was 03/15/2016.

What end date was used in your GYRE average annual return calculation?

✔️Accepted answer: The end date was 03/13/2026.

If I had invested $10,000 into GYRE ten years ago, how much would I have today?

✔️Accepted answer: With dividends reinvested, as of 03/13/2026, you would have $301,678.46.

What does that work out to on a total return basis?

✔️Accepted answer: The GYRE ten year total return ending 03/13/2026 works out to 2,917.12%.

GYRE Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved